In order to assess whether the fusion protein-loaded DC vaccine can generate therapeutic antitumor effects, 2×105 lung cancer cell lines LLC, which stably expressing MSLN and PD-L1, were injected subcutaneously on the right flank of C57BL/6 mice for better later treatment and monitoring. The gene discussed is CD274; the disease is lung carcinoma.